<DOC>
	<DOCNO>NCT01598441</DOCNO>
	<brief_summary>This study design investigate treatment postoperative pulmonary hypertension iloprost inhalation child congenital heart defect . It control single-blind randomized multi-center prospective study order explore efficacy method treatment prevention pediatric pulmonary hypertension corrective open-heart surgery congenital heart defect .</brief_summary>
	<brief_title>Multicenter Study Iloprost Inhaled Pulmonary Hypertension After Repair Congenital Heart Diseases ( CHD )</brief_title>
	<detailed_description>Primary objective : 1 . To evaluate effect iloprost inhale postoperative PH biventricular repair CHD . 2 . To verify benefit iloprost inhaled improve hemodynamics biventricular repair CHD . Secondary objective : 1 . To investigate preventive effect iloprost inhale life-threatening PHC occur immediately complex congenital heart surgery occur wean cardiopulmonary bypass . 2 . To explore potential iloprost inhale reduce early mortality PHC decrease use ECMO/VAD .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>CHD child associate PH risk factor accept biventricular repair Pp/Ps &gt; = 0.75 ( surgery ) Pp/Ps &gt; = 0.5 ( surgery ) severe mitral stenosis obstructive drainage pulmonary vein platelet count &lt; 50,000,000,000/L &amp; obvious bleeding</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>pulmonary hypertension , pulmonary hypertensive crisis</keyword>
</DOC>